;CONSTITUTION: In a medicine containing box 2, various kinds of injections of shapes of an ampoule and a vial are aligned and contained vertically in a state that they are laid down in a cartridge 22 every inje
Preferably, Compounds (I) of this invention are given to a patient in forms of pharmaceutical preparation, e.g. powder, dry syrup, tablets, troches, granules, capsules, pills, suppositories, injections, ointments, dispersions, inhalant, suspensions, solutions, emulsions, syrups and elixirs. They...
the bottle having been equipped with de-aeration suitable to function regarding medicinal solution. If this solution is intended for injections, the ferrule will be a needle. If this solution is meant to be transferred to a transfusion bag, the ferrule will be a trocar. If the solution is me...
N1 represents normalization solution; LS represents a laboratory standard HPMCAS; S1 and S2 represent standard solutions one and two, respectively; T1, T2, T3, T4, and T5 represent test sample solutions and W represents water injection. (2×) and (5×) denote the number of injections of the...
gel lines the mucosal surface thereby delivering the active component and optimising absorption. Accordingly, products prepared in accordance with the process of the present invention represent convenient solid oral delivery forms for therapeutically active components that may replace the need for injections...
21.A process for preparing a liquid pharmaceutical formulation containing a complex of macrocyclic chelate with a lanthanide and a mol/mol amount of free macrocyclic chelate of between 0.002% and 0.4%, said macrocyclic chelate being DOTA and said lanthanide being gadolinium, said process comprising t...
INFECTION: Three New Zealand White female rabbits (4-6 weeks old, 2.5-5.0 kg) were anaesthetized by standard intramuscular injections of ketamine and xylazine. A 3.5 inch french tomcat catheter was introduced into the right nostril and 100 μL of the virus inoculation solution was released onto...
14.A method of implanting chondrocyte cell suspension for autologous chondrocyte transplantation comprising(i) drawing 1 ml of nutrient media from vial 1, mixing with fibrin (concentration ranging from 72 to 110 mg) in vial 2, mixing and aspirating the contents into syringe A;(ii) drawing 1 ml...
The other parenteral formulation comprises aqueous solutions of paracetamol in a concentration of 10 mg/ml, presented in 50 ml and 100 ml vials providing 500 mg and 1000 mg of paracetamol per vial respectively. These dosage forms are administration only by intravenous infusion and obviously unsuitab...
The lyophilized composition according to the present invention can be used for such applications as injections and as culture medium for cell therapy using an aqueous solvent such as water or a buffer solution. The α-glycosylceramide compound as the active component used in the composition of the...